Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.2%

1 terminated out of 46 trials

Success Rate

95.5%

+8.9% vs benchmark

Late-Stage Pipeline

13%

6 trials in Phase 3/4

Results Transparency

14%

3 of 21 completed with results

Key Signals

3 with results95% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (13)
Early P 1 (1)
P 1 (1)
P 2 (9)
P 3 (4)
P 4 (2)

Trial Status

Completed21
Unknown11
Recruiting7
Not Yet Recruiting3
Withdrawn3
Terminated1

Trial Success Rate

95.5%

Benchmark: 86.5%

Based on 21 completed trials

Clinical Trials (46)

Showing 20 of 20 trials
NCT06904274Phase 3RecruitingPrimary

Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

NCT07436793Phase 2Not Yet Recruiting

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

NCT05903131Phase 2RecruitingPrimary

Uterine Preservation Via Lifestyle Transformation

NCT05829460Phase 2WithdrawnPrimary

Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

NCT07298707Not Yet Recruiting

Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up

NCT06784024Not ApplicableCompletedPrimary

Topical Lidocaine vs. Traditional Management in Manual Vacuum Aspiration Pain Management.

NCT07137299Not Yet Recruiting

POPQ Associated With Total Laparoscopic Hysterectomy

NCT07077876Recruiting

Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment

NCT07048327Recruiting

Cohort Study of Intrauterine Diseases

NCT01685762Early Phase 1CompletedPrimary

Metformin for the Treatment of Endometrial Hyperplasia

NCT05257057Completed

Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome

NCT03207126Not ApplicableCompleted

Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?

NCT06524934Not ApplicableCompleted

Virtual Reality's Role in See&Treat Hysteroscopy

NCT06501846Not ApplicableRecruiting

Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.

NCT06417736Not ApplicableRecruiting

Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women

NCT05378152Not ApplicableCompleted

Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity

NCT06171581Not ApplicableUnknown

Effect of Stress Ball Use on Anxiety Level During Endometrial Biopsy Procedure

NCT05697601Unknown

Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools

NCT04897217Phase 3WithdrawnPrimary

Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia

NCT03917147CompletedPrimary

Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination

Scroll to load more

Research Network

Activity Timeline